NCT04332653 2026-03-09NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsNeoImmuneTechPhase 1/2 Completed215 enrolled 30 charts
NCT07162883 2025-09-09Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Qilu Pharmaceutical Co., Ltd.Phase 3 Not yet recruiting122 enrolled
NCT02909452 2022-01-25Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsSyndax PharmaceuticalsPhase 1 Completed30 enrolled